TABLE 2.
Prevalence of HPV Types and HPV Groups in Paired Vaginal (V) and Cervical (C) Specimens, and Their Ratio (V/C), From 353 Women
| V | C | V/C | |
|---|---|---|---|
| HPV type | |||
| HPV6 | 1.4 | 0.9 | 1.7 |
| HPV11 | 0.3 | 0.0 | |
| HPV16 | 3.1 | 4.0 | 0.79 |
| HPV18 | 0.3 | 1.4 | 0.20 |
| HPV26 | 0.3 | 0.0 | |
| HPV31 | 3.1 | 2.8 | 1.1 |
| HPV32 | 1.4 | 0.9 | 1.7 |
| HPV33 | 0.6 | 0.9 | 0.67 |
| HPV35 | 1.4 | 1.7 | 0.83 |
| HPV39 | 0.9 | 1.7 | 0.75 |
| HPV40 | 0.6 | 0.3 | 2.0 |
| HPV45 | 0.9 | 0.9 | 1.0 |
| HPV51 | 2.6 | 2.0 | 1.3 |
| HPV52 | 2.0 | 2.0 | 1.0 |
| HPV53 | 2.3 | 2.6 | 0.89 |
| HPV54 | 0.6 | 0.3 | 2.0 |
| HPV55 | 0.3 | 0.3 | 1.0 |
| HPV56 | 2.0 | 1.4 | 1.4 |
| HPV58 | 3.4 | 3.7 | 0.92 |
| HPV59 | 0.9 | 1.4 | 0.60 |
| HPV61* | 3.7 | 1.4 | 2.6 |
| HPV62 | 1.4 | 0.3 | 5.0 |
| HPV66 | 0.0 | 0.9 | 0.0 |
| HPV67 | 0.0 | 0.3 | 0.0 |
| HPV68 | 0.0 | 0.3 | 0.0 |
| HPV70 | 3.1 | 1.4 | 2.2 |
| HPV71 | 4.0 | 3.7 | 1.1 |
| HPV72 | 1.4 | 0.9 | 1.7 |
| HPV73 | 0.6 | 0.6 | 1.0 |
| HPV81 | 1.7 | 0.9 | 2.0 |
| HPV82v | 0.3 | 0.6 | 0.5 |
| HPV83 | 1.4 | 0.3 | 5.0 |
| HPV84 | 2.3 | 1.1 | 2.0 |
| HPV85* | 2.3 | 0.6 | 4.0 |
| HPV group | |||
| Any HPV* | 42.5 | 33.7 | 1.3 |
| Carcinogenic HPV | 18.4 | 20.7 | 0.89 |
| Noncarcinogenic HPV* | 24.1 | 13.0 | 1.8 |
| α1/α8/α10 | 3.7 | 2.3 | 1.6 |
| α3/α15* | 14.2 | 7.7 | 1.9 |
| α5 | 3.1 | 2.6 | 1.2 |
| α6 | 4.5 | 4.0 | 1.1 |
| α7 | 8.2 | 6.8 | 1.2 |
| α9/α11 | 12.5 | 15.0 | 0.83 |
Definitions of the types included in carcinogenic HPV and in the different phylogenetic groups (e.g., α1/α8/α10) are presented in the methods. HPV13, 34, 42–44, 57, 64, 69, 82, and 89 were not detected in either specimen.
*
Statistically significant differences by an exact McNemar χ2 test.